QUOIN PHARMACEUTICALS, LTD. (QNRX)
Quoin Pharmaceuticals Announces Japans MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
Quoin Pharmaceuticals Announces Japans MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical